» Articles » PMID: 36765073

Integration of Single Sample and Population Analysis for Understanding Immune Evasion Mechanisms of Lung Cancer

Overview
Specialty Biology
Date 2023 Feb 10
PMID 36765073
Authors
Affiliations
Soon will be listed here.
Abstract

A deep understanding of the complex interaction mechanism between the various cellular components in tumor microenvironment (TME) of lung adenocarcinoma (LUAD) is a prerequisite for understanding its drug resistance, recurrence, and metastasis. In this study, we proposed two complementary computational frameworks for integrating multi-source and multi-omics data, namely ImmuCycReg framework (single sample level) and L0Reg framework (population or subtype level), to carry out difference analysis between the normal population and different LUAD subtypes. Then, we aimed to identify the possible immune escape pathways adopted by patients with different LUAD subtypes, resulting in immune deficiency which may occur at different stages of the immune cycle. More importantly, combining the research results of the single sample level and population level can improve the credibility of the regulatory network analysis results. In addition, we also established a prognostic scoring model based on the risk factors identified by Lasso-Cox method to predict survival of LUAD patients. The experimental results showed that our frameworks could reliably identify transcription factor (TF) regulating immune-related genes and could analyze the dominant immune escape pathways adopted by each LUAD subtype or even a single sample. Note that the proposed computational framework may be also applicable to the immune escape mechanism analysis of pan-cancer.

Citing Articles

Accurate identification of snoRNA targets using variational graph autoencoder to advance the redevelopment of traditional medicines.

Wang Z, Chen Y, Ma H, Gao H, Zhu Y, Wang H Front Pharmacol. 2025; 15():1529128.

PMID: 39834830 PMC: 11743687. DOI: 10.3389/fphar.2024.1529128.


Variations in DNA methylation and the role of regulatory factors in rice () response to lunar orbit stressors.

Du X, Zhang Y, Zhang M, Sun Y Front Plant Sci. 2024; 15:1427578.

PMID: 39610890 PMC: 11603183. DOI: 10.3389/fpls.2024.1427578.


Identification and analysis of a cell communication prognostic signature for oral squamous cell carcinoma at bulk and single-cell levels.

Zhang X, Yang F, Dong C, Li B, Zhang S, Jiao X J Cell Mol Med. 2024; 28(22):e70166.

PMID: 39580787 PMC: 11586053. DOI: 10.1111/jcmm.70166.


Predictable regulation of gut microbiome in immunotherapeutic efficacy of gastric cancer.

Gao W, Wang X, Shi Y, Wu G, Zhou M, Lin X Genes Immun. 2024; 26(1):1-8.

PMID: 39533019 DOI: 10.1038/s41435-024-00306-2.

References
1.
Chowell D, Yoo S, Valero C, Pastore A, Krishna C, Lee M . Improved prediction of immune checkpoint blockade efficacy across multiple cancer types. Nat Biotechnol. 2021; 40(4):499-506. PMC: 9363980. DOI: 10.1038/s41587-021-01070-8. View

2.
Lee W, Wang C, Lin T, Hsiao C, Luo C . CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor. Am J Physiol Endocrinol Metab. 2012; 304(1):E32-40. DOI: 10.1152/ajpendo.00083.2012. View

3.
Tan Y, Guda C . NBBt-test: a versatile method for differential analysis of multiple types of RNA-seq data. Sci Rep. 2022; 12(1):12833. PMC: 9329447. DOI: 10.1038/s41598-022-15762-x. View

4.
Jamal-Hanjani M, Quezada S, Larkin J, Swanton C . Translational implications of tumor heterogeneity. Clin Cancer Res. 2015; 21(6):1258-66. PMC: 4374162. DOI: 10.1158/1078-0432.CCR-14-1429. View

5.
Zou W, Wolchok J, Chen L . PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016; 8(328):328rv4. PMC: 4859220. DOI: 10.1126/scitranslmed.aad7118. View